← Leaderboards
Diva Del Carmen De Leon
Children'S Hosp Of Philadelphia
$8,108,270
Attributed
$11,335,300
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,589,168 · 8
FDA$746,132 · 1
By mechanism
R01$9,845,667 · 3
R56$567,970 · 1
K23$400,167 · 1
R43$298,999 · 1
R03$163,085 · 1
F32$49,412 · 1
Top collaborators
- Arupa Ganguly7 shared
- Changhong Li5 shared
- Gian Luca Araldi1 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Erik Allen Jensen$3,441,542
Others in their field
Top investigators on “Persistent Hyperinsulinemia Hypoglycemia Of Infancy”
- Charles Alfred Stanley · Children'S Hospital Of Philadelphia$8,718,690
- Show-Ling Shyng · Oregon Health & Science University$8,259,125
- Pawel Fludzinski · Amidebio, Llc$4,250,136
- Joseph Bryan · Baylor College Of Medicine$2,213,016
- Stephen F Betz · Crinetics Pharmaceuticals, Inc.$2,192,916
- Arupa Ganguly · University Of Pennsylvania$1,970,668
Research focus
Persistent Hyperinsulinemia Hypoglycemia Of InfancyChildMutationHyperinsulinismInsulin SecretionFunctional DisorderPancreasIsletHypoglycemiaPhenotypePlayAffectDiabetes MellitusGlucoseInsulinMolecularGenesGene ExpressionNeurodevelopmental ImpairmentBaseMouse ModelRegulationInfantLead
Grant awards (30)
Islet Dysregulation in Infants with Congenital Hyperinsulinism$628,722
R01 · FY2024 · DK · contact PI
Islet Dysregulation in Infants with Congenital Hyperinsulinism$694,490
R01 · FY2023 · DK · contact PI
Insulin Secretion in Hyperinsulinism Human Islets$629,484
R01 · FY2023 · DK · contact PI
Islet Dysregulation in Infants with Congenital Hyperinsulinism$928,666
R01 · FY2022 · DK · contact PI
Insulin Secretion in Hyperinsulinism Human Islets$632,476
R01 · FY2022 · DK · contact PI
Islet Dysregulation in Infants with Congenital Hyperinsulinism$737,330
R01 · FY2021 · DK · contact PI
Insulin Secretion in Hyperinsulinism Human Islets$629,097
R01 · FY2021 · DK · contact PI
Neurological Phenotyping in Hyperinsulinism â Administrative Supplement to Islet dysregulation in Infants with Congenital Hyperinsulinism$203,709
R01 · FY2021 · DK · contact PI
Islet Dysregulation in Infants with Congenital Hyperinsulinism$748,419
R01 · FY2020 · DK · contact PI
Insulin Secretion in Hyperinsulinism Human Islets$656,062
R01 · FY2020 · DK · contact PI
Islet Dysregulation in Infants with Congenital Hyperinsulinism$675,889
R01 · FY2018 · DK · contact PI
Development of novel prodrugs targeting Glutamate Dehydrogenase (GDH) for the treatment of congenital hyperinsulinemia disorder including Hyperinsulinemia-Hyperammonemia Syndrome (HHS) and SCHAD-HI.$298,999
R43 · FY2018 · DK
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$397,355
R01 · FY2017 · DK · contact PI
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$397,355
R01 · FY2016 · DK · contact PI
Congenital Hypoglycemia Disorders: Hyperinsulinism and Glycogen Storage Diseases$10,000
R13 · FY2016 · DK · contact PI
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$364,313
R01 · FY2015 · DK · contact PI
Phase 2A Study of Exendin for the Treatment of Congenital Hyperinsulinism$223,231
R01 · FY2015 · FD · contact PI
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$33,042
R01 · FY2015 · DK · contact PI
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$364,313
R01 · FY2014 · DK · contact PI
Phase 2A Study of Exendin for the Treatment of Congenital Hyperinsulinism$270,107
R01 · FY2014 · FD · contact PI
Fuel Metabolism and insulin secretion in KATP-hyperinsulinism human islets$378,813
R01 · FY2013 · DK · contact PI
Phase 2A Study of Exendin for the Treatment of Congenital Hyperinsulinism$252,794
R01 · FY2013 · FD · contact PI
Role of GLP-1 in Congenital Hyperinsulinism$289,763
R56 · FY2010 · DK · contact PI
Role of GLP-1 in Congenital Hyperinsulinism$278,207
R56 · FY2009 · DK · contact PI
Role of GLP-1 in disorders of carbohydrate metabolism in children$134,109
K23 · FY2008 · DK · contact PI
Effect of exendin-(9-39) on glucose metabolism in subjects with hyperinsulinism$80,605
R03 · FY2008 · DK · contact PI
Role of GLP-1 in disorders of carbohydrate metabolism in children$133,029
K23 · FY2007 · DK · contact PI
Effect of exendin-(9-39) on glucose metabolism in subjects with hyperinsulinism$82,480
R03 · FY2007 · DK · contact PI
Role of GLP-1 in disorders of carbohydrate metabolism in children$133,029
K23 · FY2006 · DK · contact PI
GLP-1 regulation of endocrine pancreas growth$49,412
F32 · FY2001 · DK